SCHEMBL8777026

SCHEMBL8777026

CCOc1ccc(C(Cc2ccccc2)C2NC(=O)c3ccccc32)cc1OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.43
PDE4A P27815 5/20 0.41
PDE4B Q07343 5/20 0.41
PDE4C Q08493 5/20 0.41
PDE4D Q08499 5/20 0.41
NPSR1 Q6W5P4 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 1/20 0.39
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.38
TNKS2 Q9H2K2 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
MGAM O43451 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
HPGD P15428 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8777055 0.88 TNF (0.43) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL3692514 0.86 PDE4A (0.53) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL8777030 0.86 TNF (0.40) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL8779459 0.85 TNF (0.45) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL8779469 0.84 TNF (0.42) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL7846184 0.82 PDE4A (0.60) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL825836 0.78 PDE4A (0.47) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL7836605 0.77 PDE4A (0.50) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL3697869 0.77 PDE4A (0.52) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL3690301 0.77 PDE4A (0.52) TNFPDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0800514-A1 SUBSTITUTED IMIDES AS TNF INHIBITORS CELGENE CORPORATION (US) 1997-10-15 EP disclosed
WO-1996020926-A1 SUBSTITUTED IMIDES AS TNF INHIBITORS CELGENE CORPORATION (US) 1996-07-11 WO disclosed